High-throughput screening method of recombinant engineering protein and proteasome inhibitor

The invention belongs to the field of biomedical engineering, and provides a novel recombinant protein which comprises a fusion protein formed by a TMEM8B-a protein and a reporter protein, and a novel proteasome inhibitor can be screened with high throughput by using the recombinant protein. The inv...

Full description

Saved in:
Bibliographic Details
Main Authors NI BIN, ZENG QINGJUAN, WANG LI, HUANG XINGCHUN, LIU WENLIANG, HU QIKANG, YU FENGLEI, ZENG JIN
Format Patent
LanguageChinese
English
Published 26.03.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention belongs to the field of biomedical engineering, and provides a novel recombinant protein which comprises a fusion protein formed by a TMEM8B-a protein and a reporter protein, and a novel proteasome inhibitor can be screened with high throughput by using the recombinant protein. The invention also correspondingly provides a high-throughput screening method of the proteasome inhibitor. The screening method is expected to quickly and effectively screen a new generation of proteasome inhibitor medicine which is better in effect, stronger in specificity, smaller in side effect and also plays a role in solid tumors. And for the high-throughput screening method, the whole process can be completed in a living cell state, and cell lysis or addition of an additional color development or luminescence reaction reagent is not needed, so that the high-throughput screening method is simple, convenient, rapid and accurate. The screening system constructed by the invention can be used for very conveniently scree
Bibliography:Application Number: CN202311760584